Refined structure of the doubly intercalated d(TAT(AFB)GCATA)2 Aflatoxin B1 adduct

Chemical Research in Toxicology

Volumn 11, Issue 8, 1998, Pages 873-881

  Jones, Wendelyn R ^a   Johnston, David S ^a,b   Stone, Michael P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bryan College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1;

ARTICLE; INTERCALATION COMPLEX; LIVER CARCINOGENESIS; MUTAGEN TESTING; MUTAGENESIS; ONCOGENE RAS; PROTON NUCLEAR MAGNETIC RESONANCE; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE;

AFLATOXIN B1; DNA; DNA ADDUCTS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 0031844196     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980047m     Document Type: Article

References (64)

1. Busby, W. F., Jr., and Wogan, G. N. (1984) Aflatoxins. In Chemical Carcinogens (Searle, C. E., Ed.), pp 945-1136, American Chemical Society, Washington, D.C.
2. McCann, J., Spingarn, N. E., Koburi, J., and Ames, B. N. (1975) Detection of carcinogens as mutagens-bacterial tester strains with R-factor plasmids. Proc. Natl. Acad. Sci, U.S.A. 72, 979-983.
3. 1. Proc. Natl. Acad. Sci. U.S.A. 80, 2695- 2698.
4. 1 is MucAB dependent in Escherichia colis. J. Bacterial. 170, 3415-3420.
5. 1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish. Carcinogenesis 9, 1919-1926.
6. 1 and aflatoxicol, two aflatoxins that form the same DNA adduct. Mutat. Res. 313, 25-38.
7. 1-induced rat liver tumors. Proc. Natl. Acad. Sci. U.S.A. 87, 1104-1108.
8. 1-induced hepatocellular carcinoma and adenoma in the rat: Detection by denaturing gradient gell electrophoresis. Proc. Natl. Acad. Sci. U.S.A. 90, 2045-2049.
9. Bressac, B., Kew, M., Wands, J., and Ozturk, M. (1991) Selective G to T mutations of p53 in hepatocellular carcinoma from southern Africa. Nature 350, 429-431.
10. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428.
11. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
12. Shen, H. M., and Ong, C. N. (1996) Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat. Res. 366, 23-44.
13. Soini, Y., Chia, S. C., Bennett, W. P., Groopman, J. D., Wang, J. S., DeBenedetti, V. M., Cawley, H., Welsh, J. A., Hansen, C., Bergasa, N. V., Jones, E. A., DiBisceglie, A. M., Trivers, G. E., Sandoval, C. A., Calderon, I. E., Munoz Espinosa, L. E., and Harris, C. C. (1996) An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 17, 1007-1012.
14. Lunn, R. M., Zhang, Y. J., Wang, L. Y., Chen, C. J., Lee, P. H., Lee, C. S., Tsai, W. Y., and Santella, R. M. (1997) p53 mutations, chronic hepatitis b virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57, 3471- 3477.
15. 1-induced DNA adduct formation and p53 mutations in cyp450-expressing human liver cell lines. Carcinogenesis 18, 1291-1297.
16. 1-DNA adducts and hepatitis b virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Environ. Health Perspect. 99, 199-202.
17. Chen, C. J., Yu, M. W., Liaw, Y. F., Wang, L. W., Chiamprasert, S., Matin, F., Hirvonen, A., Bell, D. A., and Santella, R. M. (1996) Chronic hepatitis b carriers with null genotypes of glutathione S-transferase m1 and t1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am. J. Hum. Genet. 59, 128-134.
18. Yu, M. W., Lien, J. P., Chiu, Y. H., Santella, R. M., Liaw, Y. F., and Chen, C. J. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis b carriers in Taiwan. J. Hepatol. 27, 320-330.
19. 450 enzymes. Chem. Res. Toxicol. 8, 218-225.
20. 1: The ultimate carcinogenic species. J. Am. Chem. Soc. 110, 7929-7931.
21. 1 exo-8,9-epoxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc. 118, 8213-8220.
22. 1 in vitro. Proc. Natl. Acad. Sci. U.S.A. 74, 1870-1874.
23. 2. J. Biomol. Struct. Dyn. 5, 1025-1041.
24. 1 adduct with the oligodeoxynucleotide d(ATCGAT). J. Am. Chem. Soc. 111, 7232-7239.
25. 2 and with plasmid pBR322 support intercalative association with the B-DNA helix. Biochemistry 28, 726-734.
26. 1H NMR spectroscopy. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions (Pullman, B., and Jortner, J., Eds.), pp 451-480, Kluwer Academic Publishers, The Netherlands.
27. Raney, K. D., Gopalakrishnan, S., Byrd, S., Stone, M. P., and Harris, T. M. (1990) Alteration of the aflatoxin cyclopentenone ring to a δ-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides. Chem. Res. Toxicol. 3, 254-261.
28. 1-8, 9-exo-epoxide. Chem. Res. Toxicol. 6, 64-68.
29. 1: Mechanistic studies. J. Am. Chem. Soc. 116, 1603-1609.
30. 1-DNA adduct. Proc. Natl. Acad. Sci. U.S.A. 93,1535-1539.
31. 2. Biochemistry 29, 10438-10448.
32. Gopalakrishnan, S., Liu, X., and Patel, D. J. (1992) Solution structure of the covalent sterigmatocystin-DNA adduct. Biochemistry 31, 10790-10801.
33. 1H NMR. Biochemistry 34, 14037-14050.
34. 1H NMR. Biochemistry 37, 4374-4387.
35. 1-N7-guanine DNA adduct situated at a unique site. Nucleic Acids Res. 24, 2821-2828.
36. Sancar, A. (1996) DNA excision repair. Annu. Rev. Biochem. 65, 43-81.
37. Schmitz, U., and James, T. L. (1995) How to generate accurate solution structures of double-helical nucleic acid fragments using nuclear magnetic resonance and restrained molecular dynamics. Methods Enzymol. 261, 3-44.
38. Murray, R. W., and Jeyaraman, R. (1985) Dioxiranes: Synthesis and reactions of methyldioxiranes. J. Org. Chem. 50, 2847-2853.
39. Borer, P. N. (1975) Handbook of biochemistry and molecular biology. p 359, CRC Press, Cleveland.
40. Macura, S., Wuthrich, K., and Ernst, R. R. (1982) The relevance of J cross-peaks in two-dimensional NOE experiments of macromolecules. J. Magn. Reson. 47, 351-357.
41. Rance, M., Bodenhausen, G., Wagner, G., Wuthrich, K., and Ernst, R. R. (1985) A systematic approach to the suppression of J crosspeaks in 2D exchange and 2D NOE spectroscopy. J. Magn. Reson. 62, 497-510.
42. Bodenhausen, G., Wagner, G., Rance, M., Sorensen, O. W., Wuthrich, K., and Ernst, R. R. (1984) Longitudinal two-spin order in 2D exchange spectroscopy (NOESY). J. Magn. Reson. 59, 542-550.
43. Plateau, P., and Gueron, M. (1982) Exchangeable proton NMR without baseline distortion, using new strong-pulse sequences. J. Am. Chem. Soc. 104, 7310-7311.
44. Hore, P. J. (1983) A new method for water suppression in the proton NMR spectra of aqueous solutions. J. Magn. Reson. 54, 539-542.
45. Bax, A., Sklenar, V., and Clore, G. M. (1987) Water suppression in two-dimensional spin-locked nuclear magnetic resonance experiments using a novel phase-cycling procedure. J. Am. Chem. Soc. 109, 6511-6513.
46. Sklenar, V., Brooks, B. R., Zon, G., and Bax, A. (1987) Absorption mode two-dimensional NOE spectroscopy of exchangeable protons in oligonucleotides. FEBS Lett. 216, 249-252.
47. Marion, D., Ikura, M., and Bax, A. (1989) Improved solvent suppression in one- and two-dimensional NMR spectra by convolution of time-domain data. J. Magn. Reson. 84, 425-430.
48. Arnott, S., and Hukins, D. W. L. (1972) Optimised parameters for A-DNA and B-DNA. Biochem, Biophys. Res. Commun. 47, 1504-1509.
49. Arnott, S., and Hukins, D. W. L. (1973) Refinement of the structure of B-DNA and implications for the analysis of X-ray diffraction data from fibers of biopolymers. J. Mol. Biol. 81, 93-105.
50. 1. Acta Crystallogr. B26, 1940-1963.
51. Stewart, J. P. (1983) MOPAC. Quantum Chem. Prog. Bull. 3, 43.
52. Borgias, B. A., and James, T. L. (1990) MARDIGRAS-a procedure for matrix analysis of relaxation for discerning geometry of an aqueous structure. J. Magn. Reson. 87, 475-487.
53. Keepers, J. W., and James, T. L. (1984) A theoretical study of distance determination from NMR. Two-dimensional nuclear overhauser effect spectra. J. Magn. Reson. 57, 404-426.
54. James, T. L. (1991) Relaxation matrix analysis of two-dimensional nuclear Overhauser effect spectra. Curr. Opin. Struct. Biol. 1, 1042-1053.
55. Brunger, A. T. (1992) X-Plor. Version 3.1. A system for X-ray Crystallography and NMR, Yale University Press, New Haven.
56. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. ( 1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4, 187-217.
57. Nilsson, L., and Karplus, M. (1986) Empirical energy functions for energy minimization and dynamics of nucleic acids. J. Comput. Chem. 7, 591-616.
58. Ryckaert, J.-P., Ciccotti, G., and Berendsen, H. J. C. (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327-341.
59. 2 to porcine pancreatic elastase. Combined use of two-dimensional transferred nuclear overhauser enhancement measurements, restrained molecular dynamics, X-ray crystallography and molecular modelling. J. Mol. Biol. 190, 259-267.
60. Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., and Haak, J. R. (1984) Molecular dynamics with coupling to an external bath. J. Phys. Chem. 81, 3684-3690.
61. Ravishankar, G., Swaminathan, S., everidge, D. L., Lavery, R. and Sklenar, H. (1989) Conformational and helicoidal analysis of 30 ps of molecular dynamics on the d(CGCGAATTCGCG) double helix: "Curves", dials, and windows. J. Biomol. Struct. Dyn. 6, 669-699.
62. Egli, M., Williams, L. D., Frederick, C. A., and Rich, A. (1991) DNA-nogalamycin interactions. Biochemistry 30, 1364-1372.
63. Frederick C. A., Williams, L. D., Ughetto, G., Van Der Marel, G. A., Van Boom, J. H., Rich, A., and Wang, A. H.-J. (1990) Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin. Biochemistry 29, 2538-2549.
64. Treiber, D. K., Zhai, X., Jantzen, H. M., and Essigmann, J. M. (1994) Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl. Acad. Sci. U.S.A. 91, 5672-5676.